Correction: Developing a Natural History Model for Duchenne Muscular Dystrophy

Jonathan Broomfield (), M. Hill, F. Chandler, M. J. Crowther, J. Godfrey, M. Guglieri, J. Hastie, J. Larkindale, J. Mumby-Croft, E. Reuben, F. Woodcock and K. R. Abrams
Additional contact information
Jonathan Broomfield: University of Leicester
M. Hill: GlaxoSmithKline
F. Chandler: Sanofi
M. J. Crowther: Karolinska Institute
J. Godfrey: JG Zebra Consulting
M. Guglieri: Newcastle University and Newcastle Hospitals NHS Foundation Trust
J. Hastie: Sanofi
J. Larkindale: Critical Path Institute
J. Mumby-Croft: Source Health Economics
E. Reuben: Duchenne UK
F. Woodcock: Source Health Economics
K. R. Abrams: University of Warwick

PharmacoEconomics - Open, 2024, vol. 8, issue 4, No 12, 643-643

Date: 2024
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s41669-024-00506-6 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharmo:v:8:y:2024:i:4:d:10.1007_s41669-024-00506-6

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/41669

DOI: 10.1007/s41669-024-00506-6

Access Statistics for this article

PharmacoEconomics - Open is currently edited by Timothy Wrightson and Christopher Carswell

More articles in PharmacoEconomics - Open from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().